A Phase 2 Trial for Patients with Newly Diagnosed High Grade Glioma Treated with Concurrent Radiation Therapy, Temozolomide, and BMX-001

Grants and Contracts Details

StatusActive
Effective start/end date4/29/195/31/23

Funding

  • BioMimetix JV LLC: $247,485.00